Narcolepsy: Congenital vs. Acquired — Causes and Onset
Etiology
Narcolepsy type 1 (with cataplexy) is caused by selective loss of orexin/hypocretin neurons in the lateral hypothalamus. This results from autoimmune destruction triggered by environmental factors (e.g., H1N1 infection/vaccination) in genetically susceptible individuals (HLA-DQB1*06:02).
Onset Patterns
- Typical: Adolescence/young adulthood (peak 15–25)
- Childhood: Can present as early as 5–10 years
- Adult-onset: 30s–40s not uncommon
- Not congenital: No evidence of in-utero onset; genetic risk ≠ birth presentation
Type 2 (Without Cataplexy)
Less understood; possibly partial orexin deficiency or distinct pathophysiology. Similar onset range.
Diagnosis
- Clinical history + polysomnography + multiple sleep latency test (MSLT)
- CSF orexin-A <110 pg/mL or <1/3 mean normal = definitive for NT1
Treatment
Wake-promoting agents (modafinil, pitolisant, solriamfetol), oxybates for cataplexy, scheduled naps, sleep hygiene.
Genetic Disorders - Related Articles
- Genetic Screening vs. Counseling: Understanding the Differences
- Paternity Testing: What Blood Type Can and Cannot Tell You
- Gilbert's Syndrome: Understanding & Managing Symptoms
- Serial Paracentesis: Procedure Steps, Indications, and Safety Monitoring
- Radial Aplasia-Thrombocytopenia Syndrome (TAR) - Symptoms, Causes & Treatment
- Tethered Cord Syndrome: Causes, Symptoms, and Treatment Options
- Amplification Technology: Applications in Disease & Gene Analysis
